STAT

Long-term study shows most prostate cancer patients don’t need aggressive treatment

The study’s duration and insights into prostate cancer make it "arguably one of the most important publications of the year."
A doctor at the University of Chicago Medical Center performs a robotic prostatectomy.

Nearly 30 years after it began, a study of prostate cancer patients shows both that the disease will not cause harm to the majority of men who have it, and that aggressive treatment is warranted for men with an intermediate risk of spread.

The nuanced results come from a , published Wednesday in the New England Journal of Medicine, that has followed 695 Swedish men since they were diagnosed with localized prostate cancer between October 1989 and February 1999.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Fauci Recovering At Home Following Hospitalization For West Nile Virus Infection
In an interview with STAT, Anthony Fauci, the former NIAID director, said he'd "never been as sick in my life" but added he's "absolutely going in the right direction."
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A California Bill To Restrain PBMs, A U.K. Trade Group Scolding Novo, And More
California lawmakers are making a last-minute push before adjourning to restrain pharmacy benefit managers amid a national effort to rein in prescription drug prices.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Obesity Drugs And Suicidal Thoughts, A FDA Official’s Conflicts, And More
A new study found that people taking GLP-1 drugs had suicidal thoughts at a higher rate, though experts have concerns about the methodology.

Related Books & Audiobooks